Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology
Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized.
Gespeichert in:
| Autor*in: |
Loria, P. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
11 |
|---|
| Übergeordnetes Werk: |
Enthalten in: No title available - 232(2014), 1, Seite 99-109 |
|---|---|
| Übergeordnetes Werk: |
volume:232 ; year:2014 ; number:1 ; pages:99-109 ; extent:11 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.atherosclerosis.2013.10.030 |
|---|
| Katalog-ID: |
ELV012605867 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV012605867 | ||
| 003 | DE-627 | ||
| 005 | 20230623100955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180602s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.atherosclerosis.2013.10.030 |2 doi | |
| 028 | 5 | 2 | |a /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica |
| 035 | |a (DE-627)ELV012605867 | ||
| 035 | |a (ELSEVIER)S0021-9150(13)00630-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Loria, P. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| 264 | 1 | |c 2014 | |
| 300 | |a 11 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. | ||
| 650 | 7 | |a Primary biliary cirrhosis |2 Elsevier | |
| 650 | 7 | |a Serum cholesterol |2 Elsevier | |
| 650 | 7 | |a Hepatocellular carcinoma |2 Elsevier | |
| 650 | 7 | |a Alcoholic liver disease |2 Elsevier | |
| 650 | 7 | |a Steatosis |2 Elsevier | |
| 650 | 7 | |a Cirrhosis |2 Elsevier | |
| 650 | 7 | |a Lipoproteins |2 Elsevier | |
| 650 | 7 | |a Nonalcoholic steatohepatitis |2 Elsevier | |
| 650 | 7 | |a Serum triglycerides |2 Elsevier | |
| 650 | 7 | |a Cardiovascular risk |2 Elsevier | |
| 650 | 7 | |a Nonalcoholic fatty liver disease |2 Elsevier | |
| 650 | 7 | |a Hepatitis B virus |2 Elsevier | |
| 650 | 7 | |a Hepatitis C virus |2 Elsevier | |
| 700 | 1 | |a Marchesini, G. |4 oth | |
| 700 | 1 | |a Nascimbeni, F. |4 oth | |
| 700 | 1 | |a Ballestri, S. |4 oth | |
| 700 | 1 | |a Maurantonio, M. |4 oth | |
| 700 | 1 | |a Carubbi, F. |4 oth | |
| 700 | 1 | |a Ratziu, V. |4 oth | |
| 700 | 1 | |a Lonardo, A. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t No title available |g 232(2014), 1, Seite 99-109 |w (DE-627)ELV012595616 |w (DE-600)1-9150 |7 nnns |
| 773 | 1 | 8 | |g volume:232 |g year:2014 |g number:1 |g pages:99-109 |g extent:11 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.atherosclerosis.2013.10.030 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_105 | ||
| 951 | |a AR | ||
| 952 | |d 232 |j 2014 |e 1 |h 99-109 |g 11 | ||
| author_variant |
p l pl |
|---|---|
| matchkey_str |
loriapmarchesinignascimbenifballestrisma:2014----:adoaclrikiieipeoyensetsscmaaienlssfiroiadocrht |
| hierarchy_sort_str |
2014 |
| publishDate |
2014 |
| allfields |
10.1016/j.atherosclerosis.2013.10.030 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica (DE-627)ELV012605867 (ELSEVIER)S0021-9150(13)00630-8 DE-627 ger DE-627 rakwb eng Loria, P. verfasserin aut Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Elsevier Marchesini, G. oth Nascimbeni, F. oth Ballestri, S. oth Maurantonio, M. oth Carubbi, F. oth Ratziu, V. oth Lonardo, A. oth Enthalten in No title available 232(2014), 1, Seite 99-109 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:232 year:2014 number:1 pages:99-109 extent:11 https://doi.org/10.1016/j.atherosclerosis.2013.10.030 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 232 2014 1 99-109 11 |
| spelling |
10.1016/j.atherosclerosis.2013.10.030 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica (DE-627)ELV012605867 (ELSEVIER)S0021-9150(13)00630-8 DE-627 ger DE-627 rakwb eng Loria, P. verfasserin aut Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Elsevier Marchesini, G. oth Nascimbeni, F. oth Ballestri, S. oth Maurantonio, M. oth Carubbi, F. oth Ratziu, V. oth Lonardo, A. oth Enthalten in No title available 232(2014), 1, Seite 99-109 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:232 year:2014 number:1 pages:99-109 extent:11 https://doi.org/10.1016/j.atherosclerosis.2013.10.030 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 232 2014 1 99-109 11 |
| allfields_unstemmed |
10.1016/j.atherosclerosis.2013.10.030 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica (DE-627)ELV012605867 (ELSEVIER)S0021-9150(13)00630-8 DE-627 ger DE-627 rakwb eng Loria, P. verfasserin aut Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Elsevier Marchesini, G. oth Nascimbeni, F. oth Ballestri, S. oth Maurantonio, M. oth Carubbi, F. oth Ratziu, V. oth Lonardo, A. oth Enthalten in No title available 232(2014), 1, Seite 99-109 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:232 year:2014 number:1 pages:99-109 extent:11 https://doi.org/10.1016/j.atherosclerosis.2013.10.030 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 232 2014 1 99-109 11 |
| allfieldsGer |
10.1016/j.atherosclerosis.2013.10.030 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica (DE-627)ELV012605867 (ELSEVIER)S0021-9150(13)00630-8 DE-627 ger DE-627 rakwb eng Loria, P. verfasserin aut Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Elsevier Marchesini, G. oth Nascimbeni, F. oth Ballestri, S. oth Maurantonio, M. oth Carubbi, F. oth Ratziu, V. oth Lonardo, A. oth Enthalten in No title available 232(2014), 1, Seite 99-109 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:232 year:2014 number:1 pages:99-109 extent:11 https://doi.org/10.1016/j.atherosclerosis.2013.10.030 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 232 2014 1 99-109 11 |
| allfieldsSound |
10.1016/j.atherosclerosis.2013.10.030 doi /export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica (DE-627)ELV012605867 (ELSEVIER)S0021-9150(13)00630-8 DE-627 ger DE-627 rakwb eng Loria, P. verfasserin aut Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Elsevier Marchesini, G. oth Nascimbeni, F. oth Ballestri, S. oth Maurantonio, M. oth Carubbi, F. oth Ratziu, V. oth Lonardo, A. oth Enthalten in No title available 232(2014), 1, Seite 99-109 (DE-627)ELV012595616 (DE-600)1-9150 nnns volume:232 year:2014 number:1 pages:99-109 extent:11 https://doi.org/10.1016/j.atherosclerosis.2013.10.030 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 AR 232 2014 1 99-109 11 |
| language |
English |
| source |
Enthalten in No title available 232(2014), 1, Seite 99-109 volume:232 year:2014 number:1 pages:99-109 extent:11 |
| sourceStr |
Enthalten in No title available 232(2014), 1, Seite 99-109 volume:232 year:2014 number:1 pages:99-109 extent:11 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Primary biliary cirrhosis Serum cholesterol Hepatocellular carcinoma Alcoholic liver disease Steatosis Cirrhosis Lipoproteins Nonalcoholic steatohepatitis Serum triglycerides Cardiovascular risk Nonalcoholic fatty liver disease Hepatitis B virus Hepatitis C virus |
| isfreeaccess_bool |
false |
| container_title |
No title available |
| authorswithroles_txt_mv |
Loria, P. @@aut@@ Marchesini, G. @@oth@@ Nascimbeni, F. @@oth@@ Ballestri, S. @@oth@@ Maurantonio, M. @@oth@@ Carubbi, F. @@oth@@ Ratziu, V. @@oth@@ Lonardo, A. @@oth@@ |
| publishDateDaySort_date |
2014-01-01T00:00:00Z |
| hierarchy_top_id |
ELV012595616 |
| id |
ELV012605867 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012605867</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623100955.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.atherosclerosis.2013.10.030</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012605867</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0021-9150(13)00630-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Loria, P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Primary biliary cirrhosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Serum cholesterol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatocellular carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcoholic liver disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Steatosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cirrhosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipoproteins</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nonalcoholic steatohepatitis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Serum triglycerides</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular risk</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nonalcoholic fatty liver disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B virus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis C virus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marchesini, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nascimbeni, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ballestri, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maurantonio, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carubbi, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ratziu, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lonardo, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">232(2014), 1, Seite 99-109</subfield><subfield code="w">(DE-627)ELV012595616</subfield><subfield code="w">(DE-600)1-9150</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:232</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:99-109</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.atherosclerosis.2013.10.030</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">232</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">99-109</subfield><subfield code="g">11</subfield></datafield></record></collection>
|
| author |
Loria, P. |
| spellingShingle |
Loria, P. Elsevier Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| authorStr |
Loria, P. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV012595616 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus Elsevier |
| topic |
Elsevier Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus |
| topic_unstemmed |
Elsevier Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus |
| topic_browse |
Elsevier Primary biliary cirrhosis Elsevier Serum cholesterol Elsevier Hepatocellular carcinoma Elsevier Alcoholic liver disease Elsevier Steatosis Elsevier Cirrhosis Elsevier Lipoproteins Elsevier Nonalcoholic steatohepatitis Elsevier Serum triglycerides Elsevier Cardiovascular risk Elsevier Nonalcoholic fatty liver disease Elsevier Hepatitis B virus Elsevier Hepatitis C virus |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
g m gm f n fn s b sb m m mm f c fc v r vr a l al |
| hierarchy_parent_title |
No title available |
| hierarchy_parent_id |
ELV012595616 |
| hierarchy_top_title |
No title available |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV012595616 (DE-600)1-9150 |
| title |
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| ctrlnum |
(DE-627)ELV012605867 (ELSEVIER)S0021-9150(13)00630-8 |
| title_full |
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| author_sort |
Loria, P. |
| journal |
No title available |
| journalStr |
No title available |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
99 |
| author_browse |
Loria, P. |
| container_volume |
232 |
| physical |
11 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Loria, P. |
| doi_str_mv |
10.1016/j.atherosclerosis.2013.10.030 |
| title_sort |
cardiovascular risk, lipidemic phenotype and steatosis. a comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| title_auth |
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| abstract |
Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. |
| abstractGer |
Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. |
| abstract_unstemmed |
Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_20 GBV_ILN_40 GBV_ILN_105 |
| container_issue |
1 |
| title_short |
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology |
| url |
https://doi.org/10.1016/j.atherosclerosis.2013.10.030 |
| remote_bool |
true |
| author2 |
Marchesini, G. Nascimbeni, F. Ballestri, S. Maurantonio, M. Carubbi, F. Ratziu, V. Lonardo, A. |
| author2Str |
Marchesini, G. Nascimbeni, F. Ballestri, S. Maurantonio, M. Carubbi, F. Ratziu, V. Lonardo, A. |
| ppnlink |
ELV012595616 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.atherosclerosis.2013.10.030 |
| up_date |
2024-07-06T16:45:38.308Z |
| _version_ |
1803848870326697984 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV012605867</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623100955.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.atherosclerosis.2013.10.030</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/export/home/cbs_olc/import_discovery/elsevier/convert/GBV-Archive_01_06_pica_neu/GBVA2014021000018.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV012605867</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0021-9150(13)00630-8</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Loria, P.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Liver regulates lipid metabolism in health and disease states. Nevertheless, the entity of cardiovascular risk (CVR) resulting from dysregulation of lipid metabolism secondary to liver disease is poorly characterized.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Primary biliary cirrhosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Serum cholesterol</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatocellular carcinoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Alcoholic liver disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Steatosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cirrhosis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipoproteins</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nonalcoholic steatohepatitis</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Serum triglycerides</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular risk</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nonalcoholic fatty liver disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis B virus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Hepatitis C virus</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Marchesini, G.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nascimbeni, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ballestri, S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maurantonio, M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carubbi, F.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ratziu, V.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lonardo, A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">No title available</subfield><subfield code="g">232(2014), 1, Seite 99-109</subfield><subfield code="w">(DE-627)ELV012595616</subfield><subfield code="w">(DE-600)1-9150</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:232</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:99-109</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.atherosclerosis.2013.10.030</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">232</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="h">99-109</subfield><subfield code="g">11</subfield></datafield></record></collection>
|
| score |
7.398883 |